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Backgrounds: It is suggested that dietary phytosterols, such as β-sitosterol (ST), have cancer chemopreventive
effects; however, studies are limited to support such claims. Here, we evaluated the efficacy of ST on three different
human cancer cell lines including skin epidermoid carcinoma A431 cells, lung epithelial carcinoma A549 cells and
breast adenocarcinoma MDA-MB-231.
Methods: Cell growth assay, cell cycle analysis, FACS, JC-1 staining, annexin V staining and immunoblotting were
used to study the efficacy of ST on cancer cells.
Results: ST (30–90 μM) treatments for 48 h and 72 h did not show any significant effect on cell growth and death
in A431 cells. Whereas similar ST treatments moderately inhibited the growth of A549 cells by up to 13% (p ≤ 0.05)
in 48 h and 14% (p ≤ 0.05-0.0001) in 72 h. In MDA-MB-231 cells, ST caused a significant dose-dependent cell
growth inhibition by 31- 63% (p ≤ 0.0001) in 48 h and 40-50% (p ≤ 0.0001) in 72 h. While exploring the molecular
changes associated with strong ST efficacy in breast cancer cells, we observed that ST induced cell cycle arrest as
well as cell death. ST caused G0/G1 cell cycle arrest which was accompanied by a decrease in CDK4 and cyclin D1,
and an increase in p21/Cip1and p27/Kip1 protein levels. Further, cell death effect of ST was associated with
induction of apoptosis. ST also caused the depolarization of mitochondrial membrane potential and increased
Bax/Bcl-2 protein ratio.
Conclusions: These results suggest prominent in vitro anti-proliferative and pro-apoptotic effects of ST in MDA-MB-
231 cells. This study provides valuable insight into the chemopreventive efficacy and associated molecular
alterations of ST in breast cancer cells whereas it had only moderate efficacy on lung cancer cells and did not show
any considerable effect on skin cancer cells. These findings would form the basis for further studies to understand
the mechanisms and assess the potential utility of ST as a cancer chemopreventive agent against breast cancer.
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Among many cancers, breast cancer in females and lung
cancer in males are the most frequently diagnosed can-
cers and the leading cause of cancer death for each sex
in both economically developed and developing coun-
tries [1]. Lung cancer accounted for 13% of the total
cases and 18% of the deaths due to cancer occurred in
2008 [1]. Skin cancer is the major cutaneous malignancy* Correspondence: ranaps@hotmail.com
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reproduction in any medium, provided the orand about 76,250 people are estimated to be diagnosed
for skin cancer in 2013 [2]. Incidence rate for melanoma
has been rising from past three decades. Breast cancer is
by far the most frequent cancer among women with an
estimated 23% of all cancers and is the most frequent
cause of cancer death in women [1].
The use of natural, synthetic or biological agents to
prevent, reverse or suppress the growth and progression
of cancer is referred as chemoprevention of cancer [3].
It is one of the most promising strategies for cancer con-
trol, and is accomplished by various means including
chemoprevention by phytochemicals from vegetables,Ltd. This is an open access article distributed under the terms of the Creative
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it as one of the most feasible means of cancer control [4].
Phytochemicals are secondary plant metabolites and have
been used for centuries throughout the world in trad-
itional cures and herbal remedies, and as ayurvedic and
homeopathic medicines in India. More recently, there has
been a considerable interest in secondary plant metabo-
lites because of their potential preventative effects on
chronic diseases including cancer.
Many studies have demonstrated that phytochemicals
in common fruits and vegetables can have complemen-
tary and overlapping mechanisms of action, including
antioxidant activity, scavenging free radicals and regula-
tion of gene expression, including oncogenes and tumor
suppressor genes, in cell proliferation and cell differenti-
ation; induction of cell-cycle arrest and apoptosis; modu-
lation of enzyme activities in detoxification, oxidation
and reduction; stimulation of the immune system; regu-
lation of hormone metabolism; and antibacterial and
antiviral effects [5-7]. Phytosterols (PS) are triterpenes
that are important structural components of plant mem-
branes. More than 200 different types of phytosterols
have been reported in plant species. The richest sources
of phytosterols are vegetable oils, nuts, cereal products,
fruits and berries [8]. Structural resemblance of PS with
cholesterol enables them to displace low-density lipopro-
tein (LDL) cholesterol in the human intestine [9]. Protect-
ive effects of PS against cardiovascular diseases (CVD),
colon and breast cancer developments have been widely
documented. The most common dietary phytosterols are
β-sitosterol, campesterol and stigmasterol. Among these,
the most abundant phytosterol is β-sitosterol. Studies
have shown that β-sitosterol exhibits anti-inflammatory,
angiogenic and immune-modulating properties [10].
β-sitosterol is reported to activate Fas signaling in breast
cancer cells [11], and induce cell cycle arrest and apop-
totic cell death in prostate cancer cells [12,13].
Herein, we evaluated the efficacy of β-sitosterol on three
different cancer cell lines including human skin epiderm-
oid carcinoma cell line (A431), human lung epithelial car-
cinoma cell line (A549) and human breast adenocarcinoma
cell line (MDA-MB-231). It was observed that as compared
to A431 and A549 cells, β-sitosterol showed prominent
growth inhibitory and pro-apoptotic activity in MDA-MB-
231 cells. Further, study provides valuable insight into the
chemopreventive efficacy and associated molecular alter-
ations of β-sitosterol in breast cancer cells in culture.
Methods
Cell lines and reagents
A431 and A549 cells were from ATCC (Manassas,
USA) and MDA-MB-231 cells were from NCCS Pune,
India. These cells were cultured in DMEM, RPMI-1640
and L-15, respectively, each with 10% fetal bovineserum, 100 units/ml penicillin and 100 μg/ml strepto-
mycin at 37°C in a humidified 95% air and 5% CO2 at-
mosphere. β-sitosterol (ST) was obtained from Sigma
Chemical Co. (St. Louis, MO, USA; Figure 1A). ST was
dissolved in DMSO and an equal amount (0.1% v/v) of
DMSO was present in all the treatment groups includ-
ing control. Anti-CDK4, cyclin D1 antibodies were
from Santa Cruz Biotechnology (CA, USA); anti-beta-
actin antibody was from Sigma; and anti-p21/Cip1,
p27/Kip1, phospho and total Erk1/2 and Akt, and HRP-
conjugated secondary antibodies were from Cell Signal-
ing Technology (MA, USA).
Cell growth and death assays
A431, A549 and MDA-MB-231 cells (1 × 105) were
plated in 60 mm culture dishes, and next day fed with
fresh medium and treated with different doses of ST (30,
60 and 90 μM) in complete medium. After 48 and 72 h
of these treatments, total cells were collected by brief
trypsinization, and washed with PBS. Total cell number
was determined by counting each sample in duplicate
using a hemocytometer under an inverted phase contrast
microscope (Carl Zeiss) using trypan blue dye. Dead
cells could not exclude the dye and showed blue staining
of the cell. Each treatment for each time point was done
in triplicates. Experiments were repeated at least two-
three times.
Cell cycle analysis
A431, A549 and MDA-MB-231 cells were grown at similar
confluency as in cell growth assay, and treated with desired
doses of ST (0, 30, 60 and 90 μM) in complete medium for
48 and 72 h. At the end of each treatment time, cells were
collected after a brief incubation with trypsin–EDTA
followed by processing for cell cycle analysis as reported
earlier [14]. Briefly, 0.5x105 cells were suspended in 0.5 ml
of saponin/propidium iodide (PI) solution [0.3% saponin
(w/v), 25 μg/ml PI (w/v), 0.1 mM EDTA and 10 μg/ml
RNase (w/v) in PBS], and incubated over night at 4°C in
dark. Cell cycle distribution was then analyzed by flow cy-
tometry using FACS Aria III flow cytometer (BD Biosci-
ences, San Jose, CA, USA) at Central Instrument Facility,
Central University of Gujarat, Gandhinagar.
Annexin V apoptosis assay
To quantify ST-induced apoptotic death of MDA-MB-
231 cells, annexin V/PI staining was performed followed
by flow cytometry, as described earlier [15]. Cells were
seeded and treated with 0, 60 and 90 μM of ST for 48 h.
Briefly, after treatment, both floating and attached cells
were pooled and subjected to annexin V/PI staining
using FITC Annexin V Apoptosis Detection Kit 1 from
BD Biosciences, USA and following the step-by-step
protocol provided by the manufacturer.
Figure 1 Effect of β-sitosterol (ST) on growth and cell death in human cancer cells. (A) Chemical structure of β-sitosterol, Chemical
formula:17-(5-Ethyl-6- methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H cyclopenta[a]phenanthren-3-ol. Cells were
plated overnight and treated with either DMSO control or 30, 60 and 90 μM β-sitosterol for 48 and 72 h. At the end of treatment, cells were
collected and counted with hemocytometer after staining with trypan blue dye using phase contrast inverted microscope for total cell number
of (B) A431, (C) A549 and (D) MDA-MB-231; and percent dead cells of (E) A431, (F) A549 and (G) MDA-MB-231. Data shown are mean ± S.E. of
triplicate samples for each treatment. #, p < 0.05; $, p < 0.01; *, p < 0.001 compared with the respective controls.
Vundru et al. BMC Complementary and Alternative Medicine 2013, 13:280 Page 3 of 9
http://www.biomedcentral.com/1472-6882/13/280Analysis of mitochondrial transmembrane potential (ΔΨ m)
To analyse mitochondrial transmembrane potential and
determine JC-1 monomer/ JC-1 dimer ratio, MDA-MB-
231 cells were seeded and treated with 0, 60 and 90 μM
of ST for 24 h. Cells were harvested, volume was ad-
justed to 1 ml for 2 × 105 cells by adding pre-warmed
(37°C) fresh cell culture medium, 2.5 μl JC-1 dye was
added from 5 mg/ml JC-1 dye stock to cell suspension.
Then cell suspension was gently mixed until dye got
properly dissolved and incubated for 10 min in dark at
37°C. Cell suspension was washed with 2 ml 1X PBS and
centrifuged at 1500 rpm for 5 min, discarded the super-
natant and repeated the wash. Cells were resuspended in
0.3 ml 1X PBS. Subsequently, cells were analyzed withBD FACS Aria III flow cytometer as reported earlier
[16]. Data was analyzed as JC-1 monomer/dimer ratio.
Immunoblot analysis
MDA-MB-231 cells were treated with ST (0, 60, and
90 μM) for 48 h and whole cell lysates were prepared as
described [17]. Protein estimation was done by Bradford
method. Lysates (60–80 μg/sample) were denatured in
SDS-PAGE sample buffer and boiled on water bath for
5 min. Samples were loaded onto 12% denaturing SDS-
PAGE gels and proteins resolved at constant voltage.
Proteins from the gel were transferred onto nitrocellu-
lose membrane using transfer assembly. Membranes
were blocked in blocking buffer for 1 h and incubated
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HRP-linked secondary antibody and processed for ECL
detection. Bands on films were scanned using high reso-
lution scanner [18].
Statistical analysis
All statistical analyses were carried out with Sigma Stat
software version 2.03 (Jandel Scientific, San Jose, CA,
USA). Student’s t-test was used for comparing the con-
trol group with treatment groups for statistical signifi-
cance. P < 0.05 was considered significant. All the
experiments were repeated at least twice with similar
results.
Results
Effect of β-sitosterol on growth and death of cancer cells
Trypan blue is a diazo dye which can not be excluded
from the dead cells. This method is also known as a dye
exclusion method. This test is used to determine the
number of viable cells present in a cell suspension. It is
based on the principle that live cells possess intact cell
membranes that exclude dyes such as trypan blue,
whereas in dead cells the dye is not excluded out. In this
test, a cell suspension is mixed with dye and then micro-
scopically examined for live and dead cells. The viable
cells will have a clear cytoplasm whereas non-viable cells
will have blue colour. A431 cells were treated in expo-
nential growth phase with different doses of ST (30, 60
and 90 μM) for 48 and 72 h. There was no significant
difference between the control and ST treatments in
total cell number (Figure 1B). We also did not observe any
considerable difference in cell death of A431 cells after ST
treatments (Figure 1E). In case of A549 cells, there was a
significant decrease in total cell number by 8.2% (p ≤ 0.05)
to 13.3% (p ≤ 0.05) in 48 h and 3.4% (p ≤ 0.05) to 13.7%
(p ≤ 0.0001) in 72 h (Figure 1C). The increase in cell death
of A549 cells was not significant except at 72 h of 90 μM
ST treatment (Figure 1F).
In case of MDA-MB-231 cells, there was a strong and
significant cell growth inhibition which accounted for
31% (p ≤ 0.0001) to 63% (p ≤ 0.0001) in 48 h and 40%
(p ≤ 0.0001) to 50% (p ≤ 0.0001) in 72 h (Figure 1D). The
increase in cell death was about 2% (p ≤ 0.05) to 15%
(p ≤ 0.0001) in 48 h and 1% (p ≤ 0.05) to 4% (p ≤ 0.0001)
in 72 h of ST treatments as compared to their respective
controls (Figure 1G). These results suggested better anti-
proliferative and cell death inducing effect of ST on
MDA-MB-231 breast cancer cells as compared to skin
carcinoma A431 and lung carcinoma A549 cells.
Effect of β-Sitosterol on cell cycle progression of cancer
cells
Cell cycle analysis was done by quantitation of DNA
content using propidium iodide fluorescent dye for eachphases of the cell cycle by flow cytometry. The fluores-
cence intensity of the stained cells at certain wavelengths
will therefore correlate with the amount of DNA they
contain. A431 cells were treated with different doses of
ST (30, 60 and 90 μM) for 48 and 72 h. Cell cycle distri-
bution analysis of A431 cells showed that, there were 3%
and 5% increases in G2/M phase of cell population
(Additional file 1: Figure S1A) in 48 and 72 h of ST
treatments, respectively. A549 cells showed 4% increase
in S phase in 48 h of ST treatments (Additional file 1:
Figure S1B). MDA-MB-231 cells showed 5% and 3% in-
creases in G1 phase in 48 h and 72 h of ST treatments,
respectively (Additional file 1: Figure S1C). Overall, only
a moderate effect of ST was observed on cell cycle pro-
gression of cancer cells.
Effect of β-Sitosterol on G0/G1 phase cell cycle protein
levels in MDA-MB-231 cells
Western blot analysis was done to study the molecular
effect of ST on cell cycle regulatory molecules including
cyclin-dependent kinase (CDK), Cyclin and CDKI
(CDK inhibitor), which were involved in the G0/G1 ar-
rest. Since we observed a moderate G0/G1 arrest in
MDA-MB-231 cells, we analysed these cells after ST
(60–90 μM) of 48 h that showed a dose-dependent de-
crease in CDK4 and cyclin D1 protein levels with stron-
ger effect at higher concentration (Figure 2A). We also
examined the effect of ST treatment on negative regulator
of cell cycle, i.e. (CDKI) such as p21/Cip1 and p27/Kip1,
that controls the activity of CDK through various phases
of cell cycle, including G0/G1. We observed an increase in
p21/Cip1 and p27/Kip1 protein levels which were rela-
tively higher at 90 μM concentration of ST and may ex-
plain the effect for G0/G1 arrest compared to control
(Figure 2A). These results suggest that ST induced G0/G1
arrest in MDA-MB-231 cells could be mediated via
modulation of CDK-cyclin-CDKI protein levels.
Effect of β-Sitosterol on Erk1/2 and Akt activation in
MDA-MB-231 cells
After 48 h of ST treatment we observed a dose-
dependent increase in Erk1/2 phosphorylation without
any change in its total protein level (Figure 2B). How-
ever, we did not observe any considerable change in pro-
tein levels of p-Akt and total Akt as compared to
control (Figure 2B). These results suggest that ST may
preferentially activate Erk1/2 signaling for its growth in-
hibitory and cell death inducing effects on MDA-MB-
231 cells.
Effect of β-Sitosterol on apoptotic cell death in MDA-MB-
231 cells
Apoptosis is a cell death process characterized by mor-
phological and biochemical features occurring at different
Figure 2 Effect of β-sitosterol (ST) on G0/G1 phase cell cycle regulators and mitogenic and survival signaling in breast cancer cells. MDA-
MB-231 cells were treated with either DMSO control or various doses of β-Sitosterol (60 and 90 μM) for 48 h. At the end of these treatments, cell lysate
was prepared and western blot analysis was performed. Membranes were probed with (A) anti-cyclin D1, CDK-4, p21/Cip1, p27/Kip1, and (B) anti-p-
Erk1/2, Erk1/2, p-Akt and Akt antibodies followed by peroxidase-conjugated appropriate secondary antibodies, and visualized by ECL detection system.
Membranes were striped and re-probed with anti-β actin for loading control.
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phatidyl serine to the outer layer of the membrane. This
occurs in the early phases of apoptotic cell death during
which the cell membrane remains intact [19]. The morph-
ology of MDA-MB-231 cells as compared to A431 and
A549 cells after 48 h of ST treatment suggests that cells
may undergo apoptosis (Figure 3). To investigate this pos-
sibility MDA-MB-231 cells were treated with 60 and
90 μM of ST for 48 and 72 h, and stained with FITC-
annexin V and analyzed by flow cytometry. There was up
to 2-fold (p ≤ 0.05) increase in apoptotic cell population
following ST treatment (data not shown).
Bcl-2 is anti-apoptotic protein whereas Bax is a pro-
apoptotic protein, and ration of both is known to deter-
mine the apoptotic response of the cell. To investigate
the anti-apoptotic and pro-apoptotic gene expression,
western blotting was performed against Bcl-2 and Bax
proteins. A concentration-dependent decrease was ob-
served in Bcl-2 protein level whereas Bax showed a
moderate concentration-dependent increase after 48 h
of ST treatment (Figure 4A). There was a 2–4 fold in-
crease in Bax/Bcl-2 ratio (Figure 4B), suggesting that in-
duction of apoptosis involving mitochondria could be
one of the mechanisms of cell death induced by ST.
Effect of β-Sitosterol mitochondrial membrane potential
in MDA-MB-231 cells
The loss of mitochondrial membrane potential is a hallmark
for apoptosis [20]. JC-1(5,5″,6,6″- tetrachloro-1,1″,3,3″-
tetraethylbenzimidazolylcarbocyanineiodide) is used mostly
for detecting mitochondrial depolarization occurring in
the early stages of apoptosis. It exhibits potential-
dependent accumulation in mitochondria, indicated by
a fluorescence emission shift from green to red. In non-
apoptotic cells, JC-1 exists as dimer and accumulates as
aggregates in the mitochondria which stains red.
Whereas, in apoptotic and necrotic cells, JC-1 exists in
monomeric form in cytosol and stains the cytosolgreen. Changes in the mitochondrial membrane poten-
tial (ΔΨ) were analyzed using JC-1 dye.
Cells were similarly seeded and treated as in apoptosis
assay. After treatment cells were harvested and proc-
essed for JC-1 staining and subjected to flow cytometry.
Red to green shift suggests the shift from JC-1 dimer to
JC-1 monomer (Figure 5A). Results show that there was
a significant increase in monomer/dimer ratio which
accounted for 4.5 fold increase (p ≤ 0.05) at 60 μM ST,
and 5-fold increase (p ≤ 0.001) at 90 μM ST after 24 h of
treatment (Figure 5B). This result suggests that ST
causes depolarization of mitochondrial membrane po-
tential which could be linked with the induction of
apoptosis in breast cancer cells.
Discussion
Chemoprevention is a promising strategy which involves
intervention by natural and synthetic agents at early
stages in the disease process or in high risk individuals
to reduce the development of cancer [21]. This strategy
is promising for reducing cancer incidence both in
well-defined high-risk groups of people as well as in the
general population. There is an urgent need to explore
potent, non-toxic and less expensive chemopreventive
agents that inhibit cancer growth and progression.
Our present investigation of ST against human skin
epidermoid carcinoma cell line A431, human lung epi-
thelial carcinoma cell line A549 and human breast
adenocarcinoma cell line MDA-MB-231 is an effort to
find its anticancer efficacy in different epithelial cancers.
The results of cell counting data clearly show that ST
does not have any significant effect on cell growth, cell
death and cell cycle progression in A431 cells. However,
a minor but considerable effect was observed only for
cell growth inhibition without any effect on cell death or
cell cycle progression in A549 cells. In case of MDA-
MB-231 cells, ST showed a significant growth inhibition,
cell death and cell cycle arrest. These observations
Figure 4 Effect of β-sitosterol (ST) on apoptosis and Bax/Bcl-2 ratio in breast carcinoma cells. MDA-MB-231 cells were treated with DMSO
(control) or 60 and 90 μM ST for 48 h. (A) Western blot analyses were performed to examine the expression level of Bax and Bcl-2 proteins.
Membranes were probed with anti-Bax and Bcl-2 antibodies followed by peroxidase-conjugated appropriate secondary antibodies, and visualized by
ECL detection system. Membrane was striped and re-probed with anti-β actin for loading control. Densitometric value of bands are shown below each
band as fold change from that of control and corrected with loading control (B) Represents the ratio of Bax/Bcl-2 protein expression levels.
Figure 3 Effect of β-sitosterol (ST) on cell morphology of human skin epidermoid carcinoma, human lung epithelial carcinoma and
human breast carcinoma cells. (A & B) A431, (C & D) A549, and (E & F) MDA-MB-231 cells were treated with 90 μM ST for 48 h. A, C and E
represents untreated cells whereas B, D and F represents the cells treated with ST. Arrows indicate the shrinkage of cell with condensed nuclei
which may apoptotic in nature.
Vundru et al. BMC Complementary and Alternative Medicine 2013, 13:280 Page 6 of 9
http://www.biomedcentral.com/1472-6882/13/280
Figure 5 Effect of β-sitosterol (ST) on mitochondrial membrane potential in breast carcinoma cells. MDA-MB-231 cells were treated with
DMSO (control) or 60 and 90 μM ST for 24 h. (A) Mitochondrial membrane potential was measured by JC-1 staining and analyzed by flow
cytometry as described in Methods. (B) The quantitative data is presented as means of 590 nm/520 nm (P2/P1) emission spectrum. The data
shown are mean ± S.E. of triplicate samples for each treatment. #, p < 0.05; *, p < 0.001 compared with control.
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and breast cancer cells which is in order of A431 < A549
< <MDA-MB-231.
The cancer chemopreventive strategies include the tar-
geting of limitless replication potential and deregulated
cell cycle progression in cancer cells [22]. Cell cycle pro-
gression is mediated by the activity of cyclin-dependent
kinases (CDK) in complex with regulatory subunit
cyclins [23]. A frequent target in carcinogenesis is the
deregulation of G1 to S phase progression of the cell
cycle [24]. Cyclin D1 is a key regulatory protein at G1/S
checkpoint of the cell cycle that forms complexes with
CDK4 or CDK6. It is considered as an oncogene, and over-
expressed in many cancers, including prostate, breast,
esophagus, lung, head and neck and colon [25,26]. It acts
as a growth sensor and provides a link between mitogenic
stimuli and the cell cycle. CDK4 is a key factor in promot-
ing the initiation and development of tumors [27], and
amplified and over expressed in a number of human tu-
mors including the gliomas, sarcomas, breast tumors and
colorectal carcinomas [28]. Since we observed considerable
G1 phase arrest in MDA-MB-231 cells, we also did ana-
lysis for the cyclin D1 and CDK4 protein levels which were
decreased after ST treatment. This suggests that down-
regulation of cyclin D1 and CDK4 may be associated with
ST-induced G1 phase arrest in breast carcinoma cells.
Cyclin-dependent kinase inhibitors (CDKI) are tumor
suppressor proteins that bind to active CDK-cyclincomplexes and inhibit their kinase activities [29]. p21/
Cip1 is a universal CDKI and plays a critical role in the
cellular response for cell cycle arrest [30]. p27/Kip1 is
another important member of CDKI which connects the
anti- proliferative signals for cell cycle arrest [31]. Lower
level of p27/Kip1 protein is known as a prognostic
marker for many cancers [32].
Our study showed that ST increases p21/Cip1 and
p27/Kip1 protein levels in MDA-MB-231 cells, and thus
it can also take part in inhibiting the kinase activity of
CDK. Together, ST-induced G1 arrest could be mediated
via down-regulation of CDK 4 and cyclin D1, and up
regulation of p21/Cip1 and p27/Kip1 in MDA-MB-231
cells. Furthermore, the changes observed at molecular
level suggest that these CDKI might be having alterna-
tive mechanism/s such as apoptosis, other than their cell
cycle effect, however, further studies are needed to ex-
plore such assumptions.
Apoptosis is suggested as one of the major mecha-
nisms for the targeted therapy of various cancers includ-
ing breast cancer [33]. Most of the presently available
cytotoxic anticancer drugs mediate their effect via apop-
tosis in cancer cells [34]. Changes in negatively charged
phosphatidyl serine (PS) asymmetry in cell membrane is
analyzed by its binding with annexin V conjugated with
FITC by flow cytometry. Annexin V analysis suggests
that ST caused cell death is mainly because of apoptosis
induction in MDA-MB-231 cells. The longer exposure
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fect for apoptosis; however, the higher dose (90 uM)
achieved its maximum effect at 48 h after the treatment.
Next, we explored the molecular alterations associated
with apoptosis.
The Bcl-2 family includes both anti–apoptotic (e.g.,
Bcl-2 itself ) and pro–apoptotic (e.g., Bax) proteins. Their
expression levels, interaction, ratio, and translocation of
different members determine the overall pro–apoptotic
or anti–apoptotic fate of the cell [35]. The increased ex-
pression of Bax is often associated with the increased
apoptosis whereas the increased expression of Bcl-2 is
associated with the inhibition of apoptosis and cell sur-
vival mechanisms [36]. Western blotting analysis showed
a decrease in expression level of Bcl-2 and an increase in
expression level of Bax. Furthermore, there was a strong
increase in Bax to Bcl-2 ratio, which is known to favor
apoptosis [36] suggesting that ST caused increase in
Bax/Bcl-2 ratio may play a significant role in induction
of apoptosis in MDA-MB-231 cells. To further investigate
the molecular changes associated with apoptosis induction
by ST in MDA-MB-231 cells, mitochondrial membrane
potential was measured. ST caused the depolarization of
mitochondrial membrane potential which is associated
with the induction of an early apoptotic event leading to
mitochondrial apoptosis in cells.
Conclusions
The current study shows that β-Sitosterol (ST), a dietary
phytosterol has stronger anticancer activity against
breast cancer cells compared to lung and skin cancer
cells which may be attributed to the differential expres-
sion of genes including hormones, receptors and tissue
specific proteins (Additional file 2: Figure S2). Along
with anti-proliferative and growth inhibitory effect, ST
induced G0/G1 cell cycle arrest via modulation of cell
cycle regulators CDK4, cyclin D1, p21/Cip1and p27/
Kip1 breast cancer cells. Further ST caused cell death in-
volves the induction of apoptosis in breast cancer cells
via mitochondrial membrane depolarization and in-
crease in Bax/Bcl-2 ratio. This study provides valuable
insight into the chemopreventive efficacy and associated
molecular alterations of ST in breast cancer cells. How-
ever, further studies are needed to understand and assess
the potential clinical utility of ST as a chemopreventive
agent against breast cancer.
Additional files
Additional file 1: Figure S1. Effect of β-sitosterol (ST) on cell cycle
progression in cancer cells. (A) A431, (B) A549 and (C) MDA-MB-231 cells
were treated with either DMSO control or various doses of β-Sitosterol
(60 and 90 μM) for 48 and 72 h. Cell cycle analysis was performed at the
end of each treatment as detailed in Methods.Additional file 2: Figure S1. Differential effects of β-sitosterol on
human cancer cell lines. β-sitosterol up-regulates CDKIs, p21 and p27 and
down-regulates cyclin D1 and CDK4 to induce G1 arrest in breast
adenocarcinoma MDA- MB-231 cells. On the other hand, it causes an
increase in Bax/Bcl-2 ratio and mitochondrial membrane depolarization
to induce apoptosis in breast cancer cells.
Abbreviations
ST: β-sitosterol; CDK: Cyclin-dependent kinase; CDKI: Cyclin-dependent kinase
inhibitor; FACS: Fluorescence-activated cell sorting.
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